Simmons & Simmons utilises its international network to handle global patent portfolios across health and life sciences, TMT, media, telecoms and biotechnology. The team also undertakes freedom-to-operate analyses for its clients. Stephanie Nottrott, who focuses on global patent and trade mark portfolios for biotechnology, pharmaceuticals, and nanotechnology companies, leads the team. Fellow co-head Fritz Lahrtz advises on all fields of IP.
Legal 500 Editorial commentary
Accolades
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
- 'Particularly like working with Stephanie Nottrott and her team. Always helpful and interested.'
- 'Enjoyed working with the team. Good combination of prosecution and litigation.'
Key clients
- Genevant
- Samsung Bioepis
- Celanese
- Chugai Pharmaceutical Co.
- Merus N.V.
- Oberland M & V GmbH
- Roche Diagnostics GmbH
- G. Pohl-Boskamp GmbH & Co.KG
- Cellectis
- ImmunoGen
- Agenus Inc
- Akamis Bio Limited
Work highlights
Represented Roche Diagnostics and Chugai Pharmaceutical in various patent examination procedures before the European and International Patent Offices.
Supported a US/European chemical company's the prosecution of its IP portfolio in the fields of polymer chemistry and manufacturing machines, including in opposition proceedings.
Represented a global biotech company in the fields of CRISPR and Cas in several prosecution cases before the European Patent Office.
Practice head
Stephanie Nottrott; Fritz Lahrtz